|
HEATR6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62470037423645E-12 |
| Normal-vs-Stage2 |
5.82089999999758E-05 |
| Normal-vs-Stage3 |
2.43769999999088E-05 |
| Normal-vs-Stage4 |
5.503000E-03 |
| Stage1-vs-Stage2 |
3.946400E-01 |
| Stage1-vs-Stage3 |
8.122600E-01 |
| Stage1-vs-Stage4 |
3.040000E-01 |
| Stage2-vs-Stage3 |
6.021600E-01 |
| Stage2-vs-Stage4 |
7.458800E-01 |
| Stage3-vs-Stage4 |
4.595200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.09049477517942E-11 |
| Normal-vs-Asian |
1.235970E-02 |
| Caucasian-vs-AfricanAmerican |
7.223200E-01 |
| Caucasian-vs-Asian |
3.429200E-01 |
| AfricanAmerican-vs-Asian |
2.417200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
3.44169137633799E-15 |
| Male-vs-Female |
1.147820E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.32639999989226E-07 |
| Normal-vs-Extreme_Weight |
1.52510226669733E-11 |
| Normal-vs-Obese |
2.00379712822496E-11 |
| Normal-vs-Extreme_Obese |
4.236400E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.398000E-01 |
| Normal_Weight-vs-Obese |
8.847000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.837600E-01 |
| Extreme_Weight-vs-Obese |
6.826400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.278000E-01 |
| Obese-vs-Extreme_Obese |
4.699800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.23560000406553E-08 |
| Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62680979798324E-12 |
| Normal-vs-Age(81-100Yrs) |
1.011820E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.480000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.974900E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.751570E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.261700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.107530E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.434240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
1.36009999995856E-06 |
| Normal-VS-KIRP CIMP |
2.218800E-04 |
| Normal-VS-Unclassified PRCC |
2.89160000388478E-08 |
| Type1 PRCC-VS-Type2 PRCC |
2.179600E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.814500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.017800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.633700E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.476000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.226020E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.41510000384315E-08 |
| Normal-vs-N1 |
3.90709999997796E-06 |
| Normal-vs-N2 |
7.567900E-02 |
| N0-vs-N1 |
2.798400E-02 |
| N0-vs-N2 |
7.213800E-02 |
| N1-vs-N2 |
6.378000E-01 |
|
|
